Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

F-star Therapeutics, Inc. FSTX

Set alert

Price alert · FSTX

All alert types
7.12 +7.12 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
156.51M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-2.07
Beta
-0.35
Short ratio
2.59
Inst. own
44.96%
Dividend
0.00
Ex-div date
Earnings
Mar 13, 2023
50-d avg
5.63
200-d avg
5.74
1y target
7.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for FSTX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

0.38 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -2.7×
FY 2016: -3.0×FY 2017: -2.9×FY 2018: -4.5×FY 2019: -2.8×FY 2020: -2.5×FY 2021: -2.7×
FY 2016 5y median -2.8× FY 2021
P/S 3.9×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 2.3×FY 2020: 5.8×FY 2021: 3.9×
FY 2016 5y median 2.3× FY 2021
P/B 0.9×
FY 2016: 3.0×FY 2017: 2.3×FY 2018: 1.9×FY 2019: 7.6×FY 2020: 1.5×FY 2021: 0.9×
FY 2016 5y median 1.9× FY 2021
P/FCF -3.0×
FY 2016: -3.2×FY 2017: -4.4×FY 2018: -3.8×FY 2019: -2.9×FY 2020: -3.8×FY 2021: -3.0×
FY 2016 5y median -3.8× FY 2021
EV/EBITDA -0.6×
FY 2016: -2.1×FY 2017: -2.6×FY 2018: -3.1×FY 2019: -3.2×FY 2020: -2.3×FY 2021: -0.6×
FY 2016 5y median -2.6× FY 2021
EV/Sales 0.9×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 2.7×FY 2020: 4.4×FY 2021: 0.9×
FY 2016 5y median 0.9× FY 2021
FCF Yield -33.4%
FY 2016: -31.0%FY 2017: -22.6%FY 2018: -26.1%FY 2019: -34.4%FY 2020: -26.2%FY 2021: -33.4%
FY 2016 5y median -26.2% FY 2021

Profitability

Gross Margin 100.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%
FY 2016 5y median 100.0% FY 2021
Operating Margin -145.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -79.4%FY 2020: -198.9%FY 2021: -145.1%
FY 2016 5y median -79.4% FY 2021
Net Margin -147.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -81.3%FY 2020: -227.6%FY 2021: -147.8%
FY 2016 5y median -81.3% FY 2021
ROE -32.3%
FY 2016: -102.0%FY 2017: -79.7%FY 2018: -40.9%FY 2019: -269.6%FY 2020: -59.6%FY 2021: -32.3%
FY 2016 5y median -59.6% FY 2021
ROIC -27.2%
FY 2016: -85.9%FY 2017: -44.8%FY 2018: -44.4%FY 2019: -90.4%FY 2020: -47.5%FY 2021: -27.2%
FY 2016 5y median -44.8% FY 2021
ROA -25.4%
FY 2016: -66.6%FY 2017: -53.4%FY 2018: -33.4%FY 2019: -59.8%FY 2020: -40.3%FY 2021: -25.4%
FY 2016 5y median -40.3% FY 2021

Growth (YoY)

Revenue 88.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -60.3%FY 2021: 88.1%
FY 2016 FY 2021
Operating Income -37.2%
FY 2016: 0.0%FY 2017: -9.5%FY 2018: -34.0%FY 2019: 21.0%FY 2020: 0.5%FY 2021: -37.2%
FY 2016 FY 2021
EPS (diluted) 33.3%
FY 2016: 0.0%FY 2017: -4.2%FY 2018: 36.0%FY 2019: -58.7%FY 2020: -11.0%FY 2021: 33.3%
FY 2016 FY 2021
Free Cash Flow -64.7%
FY 2016: 0.0%FY 2017: -12.1%FY 2018: -51.1%FY 2019: 18.3%FY 2020: 23.8%FY 2021: -64.7%
FY 2016 FY 2021

Financial Health

Current Ratio 7.0×
FY 2016: 7.3×FY 2017: 11.5×FY 2018: 11.6×FY 2019: 0.6×FY 2020: 1.5×FY 2021: 7.0×
FY 2016 5y median 7.0× FY 2021
Quick Ratio 7.2×
FY 2016: 7.3×FY 2017: 11.5×FY 2018: 11.6×FY 2019: 0.6×FY 2020: 1.4×FY 2021: 7.2×
FY 2016 5y median 7.2× FY 2021
Debt / Equity 0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 1.8×FY 2020: 0.1×FY 2021: 0.1×
FY 2016 5y median 0.1× FY 2021
Net Debt / EBITDA 2.2×
FY 2016: 0.6×FY 2017: 1.1×FY 2018: 0.5×FY 2019: -0.5×FY 2020: 0.7×FY 2021: 2.2×
FY 2016 5y median 0.7× FY 2021
Interest Coverage -36.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -36.4×
FY 2016 5y median 0.0× FY 2021

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31